1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 02 NOVEMBER 2015

CNS Drug News 02 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Teva's Revenues Fall But Copaxone And Specialty Revenues Provide Encouragement
Industry Trend Analysis - Priority Review Heralds New Treatment For Parkinson's Disease Psychosis
Industry Trend Analysis - Biogen To Refocus After Poor Tysabri Results In SPMS
Industry Trend Analysis - Positive Alkermes Trial Results Could Open Up MS Market
Industry Brief - Canbex Initiates Phase II trial Of VSN16R In Spasticity
Industry Trend Analysis - Ketamine-Based Drugs Poised To Be The Future Of Anti-depressant Treatment
Industry Brief - Alexza Plans To Reacquire Rights From Teva For Adasuve In The US
Industry Brief - FDA Approves Dyanavel XR For ADHD
Industry Brief - Impax Gains FDA Guanfacine Approval
Industry Brief - BI/BioMed X Extend Collaboration For Novel Therapeutic In Psychiatric Diseases
Industry Brief - Elite's Abuse-Deterrent ELI-200 Phase III Study Meets Primary Endpoints
Industry Brief - FDA Approves Endo/BDSI's Belbuca For Chronic Pain Management
Industry Brief - Aurobindo Gains FDA Tramadol Approval
Industry Brief - Jubilant Gains FDA Rizatriptan Approval
Industry Brief - Charleston/Daiichi Phase III Study Of CL-108 Met Primary Endpoints
Industry Brief - Orexo Settles Fentanyl Litigation With Actavis
Industry Brief - Insys Announces Naloxone Sublingual Spray Fast Track Designation From FDA
Industry Brief - FDA Accepts Supernus' sNDA For Trokendi Label Expansion
Industry Brief - Neurocrine Initiates Phase II Study Of NBI-98854 In Tourette's
Industry Brief - Pivotal Study Design Of Newron's Sarizotan In Rett Syndrome Planned
Industry Trend Analysis - Biogen's Restructuring Will Lead To A Broader Product Base

Table Of Contents

CNS Drug News 02 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Diabetes Statistics

  • February 2017
    10 pages
  • Diabetes  

    Therapy  

View report >

Therapy Market

2 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.